Drugs / Dengushield
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03883620 | Mar → Dec 2019 | dengue disease | Serum Institute of India Pvt. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dengushield | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03883620 ↗ |
| Route | Intravenous | “Participants will be administered Dengushield 1 mg/kg as slow intravenous injection.” NCT03883620 ↗ |